Correlation Between Pulmonx Corp and Lucid Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmonx Corp and Lucid Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmonx Corp and Lucid Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmonx Corp and Lucid Diagnostics, you can compare the effects of market volatilities on Pulmonx Corp and Lucid Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmonx Corp with a short position of Lucid Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmonx Corp and Lucid Diagnostics.

Diversification Opportunities for Pulmonx Corp and Lucid Diagnostics

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pulmonx and Lucid is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pulmonx Corp and Lucid Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lucid Diagnostics and Pulmonx Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmonx Corp are associated (or correlated) with Lucid Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lucid Diagnostics has no effect on the direction of Pulmonx Corp i.e., Pulmonx Corp and Lucid Diagnostics go up and down completely randomly.

Pair Corralation between Pulmonx Corp and Lucid Diagnostics

Given the investment horizon of 90 days Pulmonx Corp is expected to generate 4.24 times less return on investment than Lucid Diagnostics. In addition to that, Pulmonx Corp is 1.31 times more volatile than Lucid Diagnostics. It trades about 0.01 of its total potential returns per unit of risk. Lucid Diagnostics is currently generating about 0.05 per unit of volatility. If you would invest  88.00  in Lucid Diagnostics on September 1, 2024 and sell it today you would earn a total of  12.00  from holding Lucid Diagnostics or generate 13.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pulmonx Corp  vs.  Lucid Diagnostics

 Performance 
       Timeline  
Pulmonx Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmonx Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Pulmonx Corp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Lucid Diagnostics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pulmonx Corp and Lucid Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmonx Corp and Lucid Diagnostics

The main advantage of trading using opposite Pulmonx Corp and Lucid Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmonx Corp position performs unexpectedly, Lucid Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will offset losses from the drop in Lucid Diagnostics' long position.
The idea behind Pulmonx Corp and Lucid Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges